Clinical Trials Directory

Trials / Completed

CompletedNCT01041872

Comparison of Different Propofol Formulations

Dose-effect of Propofol for Anesthetic Induction: Double-blind Comparison of Different Propofol Formulations Administered Alone or With Lidocaine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
212 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the influence of different propofol formulations(plain or with lidocaine)on anesthetic induction. Propofol plain or with lidocaine is administered using a closed-loop algorithm in order to reach a Bispectral Index target of 50.

Conditions

Interventions

TypeNameDescription
DRUGPropofol Astrazeneca plainPropofol with saline is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of saline.
DRUGPropofol Astrazeneca plus lidocainePropofol with lidocaine 1¨% is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of lidocaine.
DRUGPropofol-lipuro B. Braun plainPropofol with saline is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of saline.
DRUGPropofol-lipuro B. Braun plus lidocainePropofol with lidocaine 1¨% is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of lidocaine.
DRUGPropofol Fresenius plainPropofol with saline is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of saline.
DRUGPropofol Fresenius plus lidocainePropofol with lidocaine 1¨% is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of lidocaine.

Timeline

Start date
2009-12-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-01-01
Last updated
2016-09-26

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01041872. Inclusion in this directory is not an endorsement.